Clinical disease tends to emerge under defined immunologic vulnerabilities—such as HIV infection, iatrogenic immunosuppression, or monogenic CARD9 deficiency—highlighting the challenge of extrapolating murine data to the wider population. Here, CARD9 is linked to HIV infectious disease.